Vaporizing or smoking of medical cannabis in multifamily housing prohibited.
Summary
HF2198 amends Minnesota’s medical cannabis law to add a new restriction on where cannabis may be smoked or vaporized. The bill keeps existing prohibitions on using medical cannabis in certain sensitive locations, such as schools, correctional facilities, child care settings, public transportation, and while operating vehicles or transportation equipment under the influence. It also retains the ban on smoking or vaporizing medical cannabis where a minor would be exposed or in public places and places of employment.
The bill’s main change is a new prohibition on smoking or vaporizing cannabis flower, cannabis products, artificially derived cannabinoids, and hemp-derived consumer products in multifamily housing buildings, including attached balconies and patios. The only express exception is for the use of medical cannabis flower or medical cannabinoid products, which are carved out from the new multifamily housing ban. A violation would be treated as a civil administrative offense punishable by a $250 fine.
Impact
The bill would amend Minnesota Statutes 2024, section 342.56, subdivision 1, by expanding the list of prohibited consumption locations and adding a specific housing-based restriction. In practice, it would affect residents, landlords, property managers, and tenants in apartments, condominiums, and other multifamily dwellings by limiting smoking and vaporizing in shared residential settings. It would also create a new civil enforcement mechanism for violations, rather than a criminal penalty, and would apply not only to cannabis but also to certain hemp-derived consumer products and artificially derived cannabinoids.
Sentiment
Based on the bill text and available context, the measure appears to be framed as a public health and nuisance-control bill rather than a broad cannabis policy change. The absence of committee transcripts or recorded votes means there is no documented debate in the provided materials, but the structure of the bill suggests support for restricting secondhand exposure in shared housing while preserving access for medical cannabis users. Overall, the bill’s tone is regulatory and precautionary, with an explicit exception for medical use indicating an attempt to balance housing protections with patient access.
Contention
The most likely point of contention is the new ban on smoking or vaporizing in multifamily housing, since it affects private residences and could be viewed as limiting tenant autonomy or creating enforcement challenges for landlords. Another possible issue is the bill’s inclusion of hemp-derived consumer products and artificially derived cannabinoids alongside cannabis products, which may raise questions about scope and consistency. The medical cannabis exception may also draw scrutiny over how it would be applied in practice, especially in shared buildings where smoke or vapor could still affect neighbors.
Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision
Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.
Office of Cannabis Management required to establish limits on the total THC in cannabis flower and cannabis products; addition of ingredients to impart a taste or smell to cannabis products intended to be consumed through the inhalation of smoke, vapor, or aerosol prohibited; warnings about cannabis consumption required to include a warning regarding cancer; and advertisements prohibited that promote the co-consumption of alcohol and cannabis.